Spesolimab i.v.
1368-0098
Phase 3 small_molecule completed
Quick answer
Spesolimab i.v. for Hidradenitis Suppurativa is a Phase 3 program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Hidradenitis Suppurativa
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed